| scholarly article | Q13442814 |
| P2093 | author name string | Ian Roberts | |
| Richard Smith | |||
| P2860 | cites work | The role of biostatistics in the prevention, detection and treatment of fraud in clinical trials | Q53534773 |
| Discussion Sections in Reports of Controlled Trials Published in General Medical Journals | Q56689282 | ||
| How can medical journals help prevent poor medical research? Some opportunities presented by electronic publishing | Q78171131 | ||
| Treating individuals 2. Subgroup analysis in randomised controlled trials: importance, indications, and interpretation | Q81244699 | ||
| Medical journals are an extension of the marketing arm of pharmaceutical companies | Q24810066 | ||
| Outcome reporting bias in randomized trials funded by the Canadian Institutes of Health Research | Q28285027 | ||
| Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles | Q29618882 | ||
| Subgroup analysis and other (mis)uses of baseline data in clinical trials | Q30588628 | ||
| Are these data real? Statistical methods for the detection of data fabrication in clinical trials | Q30997161 | ||
| Identifying outcome reporting bias in randomised trials on PubMed: review of publications and survey of authors | Q34389549 | ||
| Discussion sections in reports of controlled trials published in general medical journals | Q34661945 | ||
| Subgroup analysis in clinical trials | Q35687525 | ||
| Relative citation impact of various study designs in the health sciences | Q36130841 | ||
| Underreporting research is scientific misconduct | Q38050046 | ||
| The effect of scientific misconduct on the results of clinical trials: a Delphi survey | Q38866325 | ||
| Trial protocols at the BMJ. | Q42519635 | ||
| The case for structuring the discussion of scientific papers | Q42762158 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P921 | main subject | patient safety | Q1475557 |
| clinical trial | Q30612 | ||
| patient | Q181600 | ||
| P304 | page(s) | e6 | |
| P577 | publication date | 2006-05-01 | |
| P1433 | published in | PLOS Clinical Trials | Q7119652 |
| P1476 | title | Patient safety requires a new way to publish clinical trials | |
| P478 | volume | 1 |
| Q33517961 | A systematic review of the reporting of Data Monitoring Committees' roles, interim analysis and early termination in pediatric clinical trials |
| Q36910183 | An update on the diagnosis of adrenal insufficiency and the use of corticotherapy in critical illness |
| Q55526642 | Can we tame the monster? |
| Q24288899 | Do simple screening statistical tools help to detect reporting bias? |
| Q26783972 | Does Publication Bias Inflate the Apparent Efficacy of Psychological Treatment for Major Depressive Disorder? A Systematic Review and Meta-Analysis of US National Institutes of Health-Funded Trials |
| Q46812494 | Dødelig psykiatri og organiseret fornægtelse |
| Q24288780 | Evolution and translation of research findings: from bench to where? |
| Q42374397 | Introducing PLoS clinical trials: a different approach to publishing trial results |
| Q24682162 | Lapses at the new England journal of medicine |
| Q42252778 | Making research articles fit for purpose: structured reporting of key methods and findings |
| Q42317700 | Marketing trials, marketing tricks - how to spot them and how to stop them |
| Q57318061 | Medical editors and trial reporting: a betrayal of patient care |
| Q37587175 | Net efficacy adjusted for risk: further developments. |
| Q35544754 | Patience and change: a conflict of interests? |
| Q21820630 | Preparing raw clinical data for publication: guidance for journal editors, authors, and peer reviewers |
| Q28748806 | Preparing raw clinical data for publication: guidance for journal editors, authors, and peer reviewers |
| Q33262004 | Publishing clinical trial results: the future beckons |
| Q28754920 | Towards agreement on best practice for publishing raw clinical trial data |
| Q28603482 | Trust, Respect, and Reciprocity: Informing Culturally Appropriate Data-Sharing Practice in Vietnam |
| Q21090135 | What should be done to tackle ghostwriting in the medical literature? |
Search more.